Fatma. Tritar
Inès Zendah
Sonia.Ben M'rad
Hafaoua. Daghfous


The Tumor Necrosis Factor · is a pro-inflammatory cytokine which plays a key role in the pathogenesis of many diseases. Therefore, the anti Tumor necrosis factors have been used for treating many inflammatory pathologies such as rheumatoid arthritis or Crohn’s disease with success. However, the use of these drugs has revealed during the formal years many side effects dominated by the tuberculosis. Lung cancer and asthma might be other side effects of the drugs. More recently they have been used for other pulmonary indications such as sarcoïdosis. Their benefits for treating asthma is being studied. Therefore, a wise use of these drugs is  mandatory to benefit from good effects and avoid hamful ones.


Anti TNF, tuberculosis, lung cancer, sarcoidosis, asthma



  1. Scott DL, Kingsley GH. Tumor Necrosis Factor Inhibitors for Rheumatoid Arthritis. NEJM 2006; 355: 704-712.
  2. Kean J, Gershon.S, Wise RP et al. Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor -Neutralizing Agent. NEJM 2001; 345: 1098-1104.
  3. Mohan VP, Scanga CAl. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 2001;69:1847-1855.
  4. Bennett AN, Wong M, Zain A, Panayi G, Kirkham B. Adalimumab-induced asthma. Rheumatology 2005;44:1199-1200.
  5. Tim Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies. Systematic Review and Meta-analysis of Rare Harmful Effects in Randomized Controlled Trials. JAMA 2006; 295: 2275-2482.
  6. Doty JD, Mazur JE, Judson MA. Treatment of Sarcoidosis With Infliximab .Chest 2005;127:1064-107.
  7. Yee A, Pochapin MB. Treatment of Complicated Sarcoidosis with Infliximab Anti-Tumor Necrosis Factor Therapy. Ann intern med 2001; 135 : 27-31
  8. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-67.
  9. Erin EM, Leaker BR, Nicholson GC, Tan AJ et al. The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma.Am J Respir Crit Care Med. 2006;174:753-62.
  10. Rouhani FN, Meitin CA, Kaler M, Miskinis-Hilligoss D, Stylianou M, Levine SJ. Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation. Respir Med. 2005;99:1175-82.
  11. Berry MA, Hargadon B, Shelley M et al. Evidence of a Role of Tumor Necrosis Factor · in Refractory Asthma.N Engl J Med 2006;354:697-708.